  See all
 | Articles: Clinical Pharmacology |
Fatal Interstitial Lung Disease After Erlotinib for Non-small Cell Lung Cancer
Journal of Thoracic Oncology, 09/03/08
 | | Sponsor |
The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung
Cancer Chemotherapy and Pharmacology, 09/02/08
Lung Function Response to 12-week Treatment with Combined Inhalation of Long-acting beta-2 Agonist and Glucocorticoid According to ADRB2 Polymorphism in Patients with Chronic Obstructive Pulmonary Disease
Lung, 09/02/08
Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer
Journal of Thoracic Oncology, 09/02/08
Phase I/II Study of Docetaxel and S-1 in Patients with Previously Treated Non-small Cell Lung Cancer
Journal of Thoracic Oncology, 09/02/08
Pharmacokinetic Analysis of Carboplatin and Etoposide in a Small Cell Lung Cancer Patient Undergoing Hemodialysis
Journal of Thoracic Oncology, 09/02/08
Effect of hydrofluoroalkane–ethanol inhalers on estimated alcohol levels in asthmatic subjects
Respirology, 08/29/08
A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)
British Journal of Cancer, 08/29/08
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
British Journal of Cancer, 08/29/08
Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy
Lung Cancer, 08/29/08
|
|
Receive daily email updates on Clinical Pharmacology
|
|
Indexed Journals: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
Read a Different Specialty |
|
|
|
|
|
Profession Index
|
|
|
|
|
|
|
 |
| Sponsor |
|
